Business / Finance

RSS

CDC invests in Donator’s unique heat stabilization technology

Denator, the Swedish-based biotechnology company specialized in biological sample preparation technologies announced today that the Center for Disease Control and Prevention, Atlanta, had made a major purchase of its proprietary heat stabilization technology Stabilizor T1™.

6 Jul 2016

Quantum Genomics initiates Phase IIa trial for heart failure

Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.

6 Jul 2016

Proscia completes $1M seed round of financing to advance cancer diagnosis, treatment

Proscia Inc., a data solutions provider for digital pathology, announced today the completion of its $1M seed round of financing.

5 Jul 2016

Illumina signs initial customer deals for new Global Screening Array

Illumina, Inc. today announced that it has signed deals with 12 customers for its new Infinium Global Screening Array (GSA).

From Illumina, Inc. 20 Jun 2016

David Gandy becomes new ambassador for Vitabiotics Wellman

Known for his passion for fitness and for the championing of top British brands, David Gandy is the new ambassador for Vitabiotics Wellman.

From Vitabiotics Ltd. 9 Jun 2016

TxCell, LIED collaborate to develop CAR-Treg-based cellular immunotherapy for bullous pemphigoid

TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany.

2 Jun 2016

New £95 million investment in pathology services set to bring major benefits to millions of patients

A new £95 million investment in laboratory testing and diagnostic services at Central Manchester University Hospitals NHS Foundation Trust will make a major impact on the wide range of general and specialist services provided to CMFT patients who come from all over the Greater Manchester region and beyond.

27 May 2016

Bifodan announces expansion of global operations

Bifodan, a distinct provider of probiotic solutions for the private label nutritional industry, announces a significant expansion of its global operations.

19 May 2016

ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

ProBioGen, a leading specialist for contract development and manufacturing of complex glycoproteins and corresponding technologies, today announced that Thermo Fisher Scientific has licensed its GlymaxX® technology for use in development of allergy diagnostics.

19 May 2016

Mazor Robotics signs strategic commercial and investment agreements with Medtronic

Mazor Robotics Ltd., a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor.

19 May 2016

CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.

18 May 2016

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Lightpoint Medical, a clinical-stage medical device company developing advanced imaging technologies for intraoperative cancer detection, announced today that the company has signed an exclusive global license agreement for a molecular imaging technology called Beta Emission Tomography, developed by Professor Harrison Barrett, Regents Professor of Radiology and Optical Science, with his student Yijun Ding and colleague Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging.

17 May 2016

Arkin Holdings and Primera Capital lead investment of $13M in BioSight

BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.

16 May 2016

Daiichi buys Japanese rights to CTL’s innovative cardiac regeneration medicine, Heartcel

Cell Therapy Ltd. today announced the granting of the Japan license for its innovative cardiac regeneration medicine, Heartcel™ (immuno-modulatory progenitor [iMP] cells) to Daiichi Sankyo.

11 May 2016

ITL Virginia successfully completes three years of operation

Monday, 1 May will see ITL celebrate an important milestone, as the company marks three years since launching its US operation, ITL Virginia.

From Vitl Life Science Solutions 5 May 2016

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Protea Biosciences Group, Inc. announced today that it had entered into an exclusive license agreement with Yale University for new technology to improve the differential diagnosis of malignant melanoma.

27 Apr 2016

METTLER TOLEDO named 'Best Weighing Company' and 'Best Laboratory Scale/Balance' in 2016 Reader’s Choice Awards

Nominated by users, METTLER TOLEDO is proud to announce that it has once again been named “Best Weighing Company” and “Best Laboratory Scale/Balance” in the Weighing Review Reader’s Choice Awards.

From Mettler-Toledo International Inc. 27 Apr 2016

Pluristem granted two key cell therapy patents in Japan

Pluristem Therapeutics Inc. (PSTI), a leading developer of placenta-based cell therapy products, has announced that the Japan Patent Office has granted the Company two key patents addressing...

14 Apr 2016

Binding Site to collarborate in iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial

Binding Site is proud to be a key collaborator with Prof Sigurdur Kristinsson of the University of Iceland in his pivotal MGUS screening study for the forthcoming iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial.

From Binding Site 14 Apr 2016

Epigenomics receives FDA approval for Epi proColon®

Epigenomics AG, the German-American cancer molecular diagnostics company, has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s lead product, Epi proColon®, the first and only FDA-approved blood-based colorectal cancer screening test.

14 Apr 2016

Business / Finance

CDC invests in Donator’s unique heat stabilization technology

Quantum Genomics initiates Phase IIa trial for heart failure

Proscia completes $1M seed round of financing to advance cancer diagnosis, treatment

Illumina signs initial customer deals for new Global Screening Array

David Gandy becomes new ambassador for Vitabiotics Wellman

TxCell, LIED collaborate to develop CAR-Treg-based cellular immunotherapy for bullous pemphigoid

New £95 million investment in pathology services set to bring major benefits to millions of patients

Bifodan announces expansion of global operations

ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

Mazor Robotics signs strategic commercial and investment agreements with Medtronic

CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Arkin Holdings and Primera Capital lead investment of $13M in BioSight

Daiichi buys Japanese rights to CTL’s innovative cardiac regeneration medicine, Heartcel

ITL Virginia successfully completes three years of operation

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

METTLER TOLEDO named 'Best Weighing Company' and 'Best Laboratory Scale/Balance' in 2016 Reader’s Choice Awards

Pluristem granted two key cell therapy patents in Japan

Binding Site to collarborate in iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial

Epigenomics receives FDA approval for Epi proColon®

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News